Type I IFN signaling in CD8- DCs impairs Th1-dependent malaria immunity.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Haque, AshrafulBest, Shannon E
Montes de Oca, Marcela
James, Kylie R
Ammerdorffer, Anne
Edwards, Chelsea L
de Labastida Rivera, Fabian
Amante, Fiona H
Bunn, Patrick T
Sheel, Meru
Sebina, Ismail
Koyama, Motoko
Varelias, Antiopi
Hertzog, Paul J
Kalinke, Ulrich
Gun, Sin Yee
Rénia, Laurent
Ruedl, Christiane
MacDonald, Kelli P A
Hill, Geoffrey R
Engwerda, Christian R
Issue Date
2014-06-02
Metadata
Show full item recordAbstract
Many pathogens, including viruses, bacteria, and protozoan parasites, suppress cellular immune responses through activation of type I IFN signaling. Recent evidence suggests that immune suppression and susceptibility to the malaria parasite, Plasmodium, is mediated by type I IFN; however, it is unclear how type I IFN suppresses immunity to blood-stage Plasmodium parasites. During experimental severe malaria, CD4+ Th cell responses are suppressed, and conventional DC (cDC) function is curtailed through unknown mechanisms. Here, we tested the hypothesis that type I IFN signaling directly impairs cDC function during Plasmodium infection in mice. Using cDC-specific IFNAR1-deficient mice, and mixed BM chimeras, we found that type I IFN signaling directly affects cDC function, limiting the ability of cDCs to prime IFN-γ-producing Th1 cells. Although type I IFN signaling modulated all subsets of splenic cDCs, CD8- cDCs were especially susceptible, exhibiting reduced phagocytic and Th1-promoting properties in response to type I IFNs. Additionally, rapid and systemic IFN-α production in response to Plasmodium infection required type I IFN signaling in cDCs themselves, revealing their contribution to a feed-forward cytokine-signaling loop. Together, these data suggest abrogation of type I IFN signaling in CD8- splenic cDCs as an approach for enhancing Th1 responses against Plasmodium and other type I IFN-inducing pathogens.Citation
Type I IFN signaling in CD8- DCs impairs Th1-dependent malaria immunity. 2014, 124 (6):2483-96 J. Clin. Invest.DOI
10.1172/JCI70698PubMed ID
24789914Type
ArticleLanguage
enISSN
1558-8238ae974a485f413a2113503eed53cd6c53
10.1172/JCI70698
Scopus Count
The following license files are associated with this item:
Related articles
- Type I interferons suppress CD4⁺ T-cell-dependent parasite control during blood-stage Plasmodium infection.
- Authors: Haque A, Best SE, Ammerdorffer A, Desbarrieres L, de Oca MM, Amante FH, de Labastida Rivera F, Hertzog P, Boyle GM, Hill GR, Engwerda CR
- Issue date: 2011 Sep
- IL-4Rα signaling by CD8α(+) dendritic cells contributes to cerebral malaria by enhancing inflammatory, Th1, and cytotoxic CD8(+) T cell responses.
- Authors: Wu X, Brombacher F, Chroneos ZC, Norbury CC, Gowda DC
- Issue date: 2021 Jan-Jun
- Spatiotemporal requirements for IRF7 in mediating type I IFN-dependent susceptibility to blood-stage Plasmodium infection.
- Authors: Edwards CL, Best SE, Gun SY, Claser C, James KR, de Oca MM, Sebina I, Rivera Fde L, Amante FH, Hertzog PJ, Engwerda CR, Renia L, Haque A
- Issue date: 2015 Jan
- Development of a Novel CD4(+) TCR Transgenic Line That Reveals a Dominant Role for CD8(+) Dendritic Cells and CD40 Signaling in the Generation of Helper and CTL Responses to Blood-Stage Malaria.
- Authors: Fernandez-Ruiz D, Lau LS, Ghazanfari N, Jones CM, Ng WY, Davey GM, Berthold D, Holz L, Kato Y, Enders MH, Bayarsaikhan G, Hendriks SH, Lansink LIM, Engel JA, Soon MSF, James KR, Cozijnsen A, Mollard V, Uboldi AD, Tonkin CJ, de Koning-Ward TF, Gilson PR, Kaisho T, Haque A, Crabb BS, Carbone FR, McFadden GI, Heath WR
- Issue date: 2017 Dec 15
- Reduction of conventional dendritic cells during Plasmodium infection is dependent on activation induced cell death by type I and II interferons.
- Authors: Tamura T, Kimura K, Yui K, Yoshida S
- Issue date: 2015 Dec